NDC 49527-953

CLINIQUE CX PROTECTIVE BASE SPF 40

Octinoxate, Octisalate, Zinc Oxide,titanium Dioxide

CLINIQUE CX PROTECTIVE BASE SPF 40 is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Clinique Laboratories Inc. The primary component is Octinoxate; Octisalate; Zinc Oxide; Titanium Dioxide.

• Product ID: 49527-953_3db07dee-3ef4-417d-a4ac-1a18421ddcb4
• NDC: 49527-953
• Product Type: Human Otc Drug
• Proprietary Name: CLINIQUE CX PROTECTIVE BASE SPF 40
• Generic Name: Octinoxate, Octisalate, Zinc Oxide,titanium Dioxide
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2005-05-01
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part352
• Labeler Name: CLINIQUE LABORATORIES INC
• Substance Name: OCTINOXATE; OCTISALATE; ZINC OXIDE; TITANIUM DIOXIDE
• Active Ingredient Strength: 8 mL/100mL; mL/100mL; mL/100mL; mL/100mL
• NDC Exclude Flag: E
• Listing Certified Through: 2018-12-31

Packaging

NDC 49527-953-01

1 TUBE in 1 CARTON (49527-953-01) > 50 mL in 1 TUBE (49527-953-02)

• Marketing Start Date: 2005-05-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49527-953-02 [49527095302]

CLINIQUE CX PROTECTIVE BASE SPF 40 CREAM

• Marketing Category: OTC monograph not final
• Application Number: part352
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2005-05-01

NDC 49527-953-01 [49527095301]

CLINIQUE CX PROTECTIVE BASE SPF 40 CREAM

• Marketing Category: OTC monograph not final
• Application Number: part352
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2005-05-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
OCTINOXATE	7.5 mL/100mL

OpenFDA Data

• SPL SET ID: 75201871-e084-48e0-9e18-a0b2bf280626
• Manufacturer:
  • CLINIQUE LABORATORIES INC
• UNII:
  • 15FIX9V2JP
  • SOI2LOH54Z
  • 4X49Y0596W
  • 4Y5P7MUD51